Lions Health: 2018 health and wellness winners

Lions Health: 2018 health and wellness winners

Here are the Lions Health winners in the health and wellness category.

WPP's Read: We're focusing on collaboration, rather than 'collapsing' agency brands and restructuring

WPP's Read: We're focusing on collaboration, rather than 'collapsing' agency brands and restructuring

Mark Read has warned against "collapsing" too many WPP agency brands and said driving greater collaboration is more important than a "major restructuring".

'Creativity is not on pause because one group is not in Cannes'

'Creativity is not on pause because one group is not in Cannes'

This year's Cannes Lions Festival will be different to any that preceded it - but then, it was always thus.

Five things for pharma marketers to know: Monday, June 18, 2018

Five things for pharma marketers to know: Monday, June 18, 2018

Quest Analytics buys BetterDoctor; Analyst Eric Schmidt to join Allogene Therapeutics; Two-thirds of Americans "very concerned" about cost of health insurance.

Confusion expected in wake of 'Right to Try' bill's signing

Confusion expected in wake of 'Right to Try' bill's signing

It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.

U.S. beefs up presence on Cannes Pharma Lions shortlist

U.S. beefs up presence on Cannes Pharma Lions shortlist

FCB Health features heavily in a rising percentage of U.S. campaigns that made it to the Pharma Lions shortlist - the company's Rich Levy is jury president this year.

How Digitas Health's Collette Douaihy does Cannes

How Digitas Health's Collette Douaihy does Cannes

Collete Douaihy, Digitas Health's executive vice president, executive creative director shares advice for navigating Cannes, her opinion on the new schedule, and how she's handling judging.

Five things for pharma marketers to know: Friday, June 16, 2018

Five things for pharma marketers to know: Friday, June 16, 2018

Eli Lilly CEO says changes needed in drug pricing system; Kentucky sues Walgreens over opioid epidemic; Teva faces migraine drug setback.

Cannes awards entries fall by a fifth in watershed year

Cannes awards entries fall by a fifth in watershed year

The number of entries to Cannes Lions has dropped by 21.4% from last year, which organisers ascribed partly to Publicis Groupe's temporary withdrawal and partly to their decision to restructure the awards programme.

Outcome Health turns to Matt McNally as CEO

Outcome Health turns to Matt McNally as CEO

Rishi Shah stepped down from the chief executive position five months ago amid fraud allegations.

FDA guidelines for payer, off-label communications: OK as long as 'truthful'

FDA guidelines for payer, off-label communications: OK as long as 'truthful'

Two FDA guidance documents aim to help pharma companies show the value of their drugs to payers beyond what's included in FDA labeling.

Five things for pharma marketers to know: Thursday, June 14, 2018

Five things for pharma marketers to know: Thursday, June 14, 2018

BIO afterparty again sparks controversy; GSK meets goal for two-drug HIV treatment; Mylan receives complete response letter for Advair generic.

'The elephant in the room': Absent Sorrell inspires anger and affection at WPP

'The elephant in the room': Absent Sorrell inspires anger and affection at WPP

In the week that former WPP chief Sir Martin Sorrell faced claims of bullying behaviour and paying for a prostitute, the ad group will be breathing a sigh of relief after an AGM that avoided a showdown.

Ogilvy stresses post-restructuring flexibility in health work

Ogilvy stresses post-restructuring flexibility in health work

The WPP agency is hoping its reorganization results in more collaboration among health and wellness staffers.

Five things for pharma marketers to know: Wednesday, June 13, 2018

Five things for pharma marketers to know: Wednesday, June 13, 2018

Drugmakers not dropping prices on Trump timeline; Azar backs insurance for those with preexisting conditions; Stryker denies interest in Boston Scientific takeover.

Sorrell's $26.7 million pay-off triggers WPP shareholder rebellion

Sorrell's $26.7 million pay-off triggers WPP shareholder rebellion

WPP faced tough questions about Sir Martin Sorrell's exit at its annual general meeting, with more than a quarter of WPP shareholders voting against his entitlement to a possible $26.7 million pay-off.

GMHC takes Blood Equality push overseas

GMHC takes Blood Equality push overseas

For the first time, the nonprofit is trying to eliminate bans on gay and bisexual men donating blood in countries other than the U.S.

WPP's Read writes to staff about importance of 'respect' in wake of Sorrell press coverage

WPP's Read writes to staff about importance of 'respect' in wake of Sorrell press coverage

WPP joint COO Mark Read has emailed all staff at the group to tell them to expect respect from their colleagues and announce a group-wide code of conduct review.

Five things for pharma marketers to know: Tuesday, June 12, 2018

Five things for pharma marketers to know: Tuesday, June 12, 2018

FDA puts Sage depression treatment on accelerated timeline; AstraZeneca, Lilly cease Alzheimer's treatment trial; Stryker makes offer for Boston Scientific.

Sorrell in the headlines over 'sex, cash, and bullying' claims

Sorrell in the headlines over 'sex, cash, and bullying' claims

Martin Sorrell's reputation is under increasing fire from the press, with both the 'Financial Times' and the 'Daily Mail' using their front pages to air allegations about his conduct today.

Five things pharma marketers need to know: Monday, June 11, 2018

Five things pharma marketers need to know: Monday, June 11, 2018

Eckert returns to lead Sprout Pharmaceuticals; Sorrell denies prostitution allegation; AHIP warns about removing key Obamacare provisions.

Sorrell denies prostitute allegation

Sorrell denies prostitute allegation

WPP's unpublished investigation into its former chief executive Martin Sorrell's conduct examined whether he used company funds to pay a prostitute, according to reports.

How Sudler Australia's Cherie Davies does Cannes

How Sudler Australia's Cherie Davies does Cannes

The creative director of Sudler Australia shares her opinion on changes to Cannes' scheduling and how she's preparing for long days spent judging.

WPP faces protest over Sorrell pay-off but Quarta is set to stay as chairman

WPP faces protest over Sorrell pay-off but Quarta is set to stay as chairman

WPP investors are set to lodge a significant protest over Sir Martin Sorrell's pay-off but executive chairman Roberto Quarta is expected to survive.

Five things for pharma marketers to know: Friday, June 8, 2018

Five things for pharma marketers to know: Friday, June 8, 2018

Novo Nordisk considers cutting 3,000 jobs; Pharma companies pressured to move birth control over the counter; Gates Foundation launches a nonprofit biotech.

Former JWT chief Gustavo Martinez exits WPP two years after sexual harassment row

Former JWT chief Gustavo Martinez exits WPP two years after sexual harassment row

Former JWT global chief executive Gustavo Martinez has departed WPP in a sign that the ad group's new leadership wants to draw a line under his controversial tenure.

How women can empower themselves to close biopharma's gender pay gap

How women can empower themselves to close biopharma's gender pay gap

Women healthcare leaders discussed the gender pay gap and tools for women to advocate for themselves on stage at MM&M's Hall of Femme event Thursday.

'Keep knocking on the door': Executives urge women to trust their potential

'Keep knocking on the door': Executives urge women to trust their potential

Life and career lessons from Novartis' Vanessa Thirion-Cullity and other executives.

Read the June 2018 Digital Edition

Read the June 2018 Digital Edition

The State of Diversity in Healthcare Marketing: For years, pharma has talked about diversity and inclusion issues in its midst, with some pundits saying the industry was slow to embrace diversity and others claiming that it's ahead of the curve.

Five things for pharma marketers to know: Thursday, June 7, 2018

Five things for pharma marketers to know: Thursday, June 7, 2018

Bayer closes Monsanto deal after lengthy antitrust review; Bezos, Dimon, Buffett pick CEO to run healthcare venture; Novartis to avoid criminal actions over Cohen payments.

AARP, tech firms to test voice-based health tools among senior set

AARP, tech firms to test voice-based health tools among senior set

Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.

How Ogilvy's Andrew Schirmer does Cannes

How Ogilvy's Andrew Schirmer does Cannes

The CEO of Ogilvy CommonHealth North America shares advice for first-time attendees at Cannes.

Five things for pharma marketers to know: Wednesday, June 6, 2018

Five things for pharma marketers to know: Wednesday, June 6, 2018

Athenahealth CEO steps down; Former Celgene chief executive wins New Jersey Senate primary; Big Pharma not planning campaign against Trump drug pricing plan.

WPP investor pressure to sell Kantar could open door to Sorrell acquisition spree

WPP investor pressure to sell Kantar could open door to Sorrell acquisition spree

Investor pressure is likely to force WPP into selling Kantar, possibly along with other assets - which could open opportunities for Sir Martin Sorrell's new vehicle S4 Capital.

'Will Marcel replace creatives?': Sadoun faces deluge of questions from Publicis staff and clients

'Will Marcel replace creatives?': Sadoun faces deluge of questions from Publicis staff and clients

Just after the launch of Marcel, Publicis chief executive Arthur Sadoun was bombarded with questions from a packed room of clients, staff, and journalists.

AstraZeneca's Olivier Nataf on how his long tenure shapes his current role

AstraZeneca's Olivier Nataf on how his long tenure shapes his current role

AstraZeneca VP, head of U.S. oncology, Olivier Nataf details how being a company lifer impacted his career.

Two drugs in the pipeline representing unique marketing challenges

Two drugs in the pipeline representing unique marketing challenges

Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.

Infographic | MSLs by the numbers

Infographic | MSLs by the numbers

Medical science liaisons are essential participants in most aspects of the commercialization process.

Five things for pharma marketers to know: Tuesday, June 5, 2018

Five things for pharma marketers to know: Tuesday, June 5, 2018

Medicare Part D brand-name drug costs up even as prescriptions fall; Gottlieb could speed up approval process for competitors of first-to-market drugs; FDA approves Filphila.

Ogilvy unveils new identity: CEO Seifert explains agency's new structure and purpose

Ogilvy unveils new identity: CEO Seifert explains agency's new structure and purpose

Ogilvy is ditching Mather, introducing a new corporate identity and cementing months of streamlining with a simplified organizational structure that chief executive John Siefert says will "build a new model for our industry".

MSLs: 'We are the connectors'

MSLs: 'We are the connectors'

Meet "the connectors" as four of the best-regarded medical science liaisons and the leader of the MSL Society discuss what they do, how they do it, and why their work is so vital.

We asked for your take on pharma's diversity push. Here are the responses

We asked for your take on pharma's diversity push. Here are the responses

MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.

Cologuard's Mark Stenhouse on bike training, his office, and his current reading list

Cologuard's Mark Stenhouse on bike training, his office, and his current reading list

Mark Stenhouse, president of Cologuard at Exact Sciences, shares his wake up routine and how he manages a busy schedule.

Merck's Keytruda continues its string of blockbuster results, but BMS' Opdivo still leads in sales

Merck's Keytruda continues its string of blockbuster results, but BMS' Opdivo still leads in sales

Although analysts predict this dynamic won't last long.

Five things for pharma marketers to know: Monday, June 4, 2018

Five things for pharma marketers to know: Monday, June 4, 2018

New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior

Tackling diversity and inclusion head-on

Tackling diversity and inclusion head-on

MM&M and Publicis Health debut results of their first Diversity Survey, detailing areas where healthcare agencies are progressing with regard to diversity and inclusion. Pharma leaders interviewed by MM&M say there are signs the industry is finally getting it right.

Cigna wants patients to start asking questions about opioids

Cigna wants patients to start asking questions about opioids

Its campaign arms patients with questions to ask their doctors before they're prescribed an opioid.

Five things for pharma marketers to know: Friday, June 1, 2018

Five things for pharma marketers to know: Friday, June 1, 2018

Opioid prescriptions drop for fifth year in a row; AstraZeneca reprimanded by U.K. regulator; Samsung partners with Babylon to bring appointments to smartphones.

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.

This nonprofit wants brands to pressure their agencies to drop tobacco clients

This nonprofit wants brands to pressure their agencies to drop tobacco clients

The Quit Big Tobacco campaign from Vital Strategies is using HP's agency diversity push as a guide.

Teva launches chronic disease patient website Life Effects

Teva launches chronic disease patient website Life Effects

The website is part of Teva's rebranding efforts, which began in March.

Five things for pharma marketers to know: Thursday, May 31, 2018

Five things for pharma marketers to know: Thursday, May 31, 2018

FDA approves first artificial iris; Trump expects voluntary drug price cuts; Novartis' head of oncology departs.

Terry Savage: What Cannes should and shouldn't be

Terry Savage: What Cannes should and shouldn't be

"Creativity in 2018 comes from everywhere" Cannes Lions' outgoing chairman says, describing what's new this year and how it differs from his first ever Cannes in 1986.

One-word answers with Publicis Groupe chairman Maurice Lévy

One-word answers with Publicis Groupe chairman Maurice Lévy

The former Publicis Groupe chief executive provides a word of advice (literally) to Sir Martin Sorrell on life "post-CEO", as well as the right time to retire and life with a beard.

The story behind Sanofi's tweet: 'Using our medicines as a crutch for bad behavior is not appropriate'

The story behind Sanofi's tweet: 'Using our medicines as a crutch for bad behavior is not appropriate'

Why Sanofi felt "obligated" to respond to Roseanne Barr's claim of "Ambien tweeting."

Ambien maker Sanofi's response to Roseanne: 'Racism is not a side effect'

Ambien maker Sanofi's response to Roseanne: 'Racism is not a side effect'

The drugmaker clapped back to Roseanne Barr's comment that she was "Ambien tweeting" when she made racist remarks about Valerie Jarrett.

Five things for pharma marketers to know: Wednesday, May 30, 2018

Five things for pharma marketers to know: Wednesday, May 30, 2018

Allergan to sell women's and infectious disease units; Large clinical trials falling out of favor; American Cancer Society recommends earlier screening for colon cancer.

Sorrell confirms adland return with 'tech, data and content'-focused S4 Capital

Sorrell confirms adland return with 'tech, data and content'-focused S4 Capital

Sir Martin Sorrell has confirmed details of his return to the front line of advertising only weeks after leaving WPP, with the launch of a new "multinational communication services business".

Marijuana: a green grey zone for patients, doctors, and pharma companies

Marijuana: a green grey zone for patients, doctors, and pharma companies

Legalization of the drug for medical use is already having an impact on prescription patterns. But for patients and doctors alike, there are a lot of unanswered questions.

Sir Martin Sorrell set to reignite career with stock market return

Sir Martin Sorrell set to reignite career with stock market return

The former WPP CEO is thought to be gearing up to acquire a new company which he will turn into a new marketing group.

Five things for pharma marketers to know: Tuesday, May 29, 2018

Five things for pharma marketers to know: Tuesday, May 29, 2018

MIT researchers develop ingestible sensor to detect intestinal bleeding; Diet Madison Avenue goes dark after defamation suit filed; Justice Department report finds Purdue knew about potential for OxyContin abuse.

How drugmakers are facing the entrance of consumer giants into healthcare

How drugmakers are facing the entrance of consumer giants into healthcare

As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.

Orphan drugs to grow twice as fast as rest of the industry: report

Orphan drugs to grow twice as fast as rest of the industry: report

Research from EvaluatePharma predicts the orphan drug market will grow 11% each year until 2024.

Accenture faces 'conflict of interest' questions over buying programmatic, auditing media

Accenture faces 'conflict of interest' questions over buying programmatic, auditing media

Specialist media consulting firms and media agencies have claimed Accenture faces a "clear conflict" of interest over the launch of its programmatic media planning and buying unit.

Five things for pharma marketers to know: Friday, May 25, 2018

Five things for pharma marketers to know: Friday, May 25, 2018

AstraZeneca lung cancer drug meets key goal; Johnson & Johnson loses another talc lawsuit; Cancer drugs account for 80% of drug sales.

GDPR: How to make sure your business is ready

GDPR: How to make sure your business is ready

As of May 25, Europe's groundbreaking General Data Protection Regulation (GDPR) will take effect, fundamentally changing the way businesses and government agencies deal with personal data.

Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug

Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug

Sun Pharma's branded prostate cancer treatment Yonsa just received FDA approval.

VIDEO: Here's how Publicis Groupe's AI-powered Marcel will look and work

VIDEO: Here's how Publicis Groupe's AI-powered Marcel will look and work

Publicis Groupe unveiled its much-anticipated AI-powered platform Marcel at its VivaTech event this morning in Paris.

Five things for pharma marketers to know: Thursday, May 24, 2018

Five things for pharma marketers to know: Thursday, May 24, 2018

Recro non-opioid injection receives complete response letter from FDA; Pfizer settles False Claims Act allegations; Medtronic reports better-than-expected profit.

Experts skeptical feds' move on Insys will tilt scales of justice against opioid maker

Experts skeptical feds' move on Insys will tilt scales of justice against opioid maker

Insys founder John Kapoor has maintained his innocence in the face of charges.

How data regulation could be good for marketing post-Cambridge Analytica

How data regulation could be good for marketing post-Cambridge Analytica

Stuart Ingis on the benefits of showing the public how advertisers and marketers use data and creating a global regulatory framework.

4As O'Brien: How healthcare marketing has changed under Trump

4As O'Brien: How healthcare marketing has changed under Trump

Speakers at the Coalition for Healthcare Communication conference discussed how regulations from the White House and FDA have affected healthcare comms.

Accenture Interactive launches programmatic unit in response to 'significant' client demand

Accenture Interactive launches programmatic unit in response to 'significant' client demand

Accenture has taken another big step into the agency space by launching a programmatic media planning and buying unit.

Five things for pharma marketers to know on Wednesday, May 23, 2018

Five things for pharma marketers to know on Wednesday, May 23, 2018

Keytruda passes late-stage trial; Astellas to cut 600 jobs in restructuring; Teva expects FDA decision on migraine drug by mid-September.

Health diagnostic startup Nanobiosym brings on Finn Partners as AOR

Health diagnostic startup Nanobiosym brings on Finn Partners as AOR

Nanobiosym hired the agency shortly after its proprietary technology was approved by the FDA.

Five things for pharma marketers to know: Tuesday, May 22, 2018

Five things for pharma marketers to know: Tuesday, May 22, 2018

Geisinger looks to expand DNA sequencing program; Celgene invests $65 million more in Evotec; Oscar launches transparency push.

Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug prices

Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug prices

The White House's strategy calls for moving expensive treatments from under Medicare Part B to Medicare Part D.

'300' director Zack Snyder takes Leukemia & Lymphoma Society campaign in bolder direction

'300' director Zack Snyder takes Leukemia & Lymphoma Society campaign in bolder direction

The Beating Cancer Is in Our Blood brand positioning was developed with Oberland.

Five things for pharma marketers to know: Monday, May 21, 2018

Five things for pharma marketers to know: Monday, May 21, 2018

FDA approves AstraZeneca potassium drug; Nabriva pneumonia treatment meets Phase III endpoints; "Bad Blood" hits bookshelves.

MM&M Hall of Femme 2018: The profiles

MM&M Hall of Femme 2018: The profiles

MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.

Meet the 2018 Women to Watch Honorees

Meet the 2018 Women to Watch Honorees

MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.

Five things for pharma marketers to know: Friday, May 18, 2018

Five things for pharma marketers to know: Friday, May 18, 2018

First preventative migraine treatment approved; NIH investigates funding for alcohol study; Trump to block federal funding for abortion clinics.

How Amazon's culture fuels innovation

How Amazon's culture fuels innovation

Shaun Qualheim from Amazon Web Services explained how the company's small teams and customer-first and failure-friendly culture promotes innovation.

'When we look at health we have to unpack emotion': More soundbites from Transforming Health

'When we look at health we have to unpack emotion': More soundbites from Transforming Health

Experts on using technology to change patient behavior and other topics.

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation

The big driver of healthcare investment in tech isn't Silicon Valley; It's the patient

The big driver of healthcare investment in tech isn't Silicon Valley; It's the patient

Digital health experts discussed how tech is disrupting the healthcare industry at the MM&M Transforming Healthcare conference.

Biden Initiative's Greg Simon: Innovation comes when health system collaborates

Biden Initiative's Greg Simon: Innovation comes when health system collaborates

The president of the Biden Cancer Initiative shared lessons learned from the White House Cancer Moonshot.

Five things for pharma marketers to know: Thursday, May 17, 2018

Five things for pharma marketers to know: Thursday, May 17, 2018

Biden Cancer Initiative chief gets Transforming Healthcare conference started; Former Novartis CEO on Cohen payments; J&J's Gorsky has advice for Trump on drug pricing plan.

Making headlines: Key moments throughout Martin Sorrell's historic career

Making headlines: Key moments throughout Martin Sorrell's historic career

A divisive figure, Sorrell's rise to the top of the ad industry was never dull. Here, we outline the key moments.

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.

Drug list prices in DTC ads? Easier said than done

Drug list prices in DTC ads? Easier said than done

For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.

Read the May 2018 Digital Edition

Read the May 2018 Digital Edition

Read the May 2018 issue in its entirety.

The future of the agency model in a post-Sorrell era

The future of the agency model in a post-Sorrell era

As WPP faces break-up calls in the wake of Sir Martin Sorrell's exit, the agency holding company model is under greater scrutiny than at any time since the 1980s.

Five things for pharma marketers to know: Wednesday, May 16, 2018

Five things for pharma marketers to know: Wednesday, May 16, 2018

Novartis' top lawyer exits after Cohen payments; More states file suit against Purdue Pharma; J&J to relaunch baby line.

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.

AstraZeneca's Joe Shields to launch Health Accelerators with Think Patients

AstraZeneca's Joe Shields to launch Health Accelerators with Think Patients

Shields will serve as president of the Think Patients subsidiary firm.

Five things for pharma marketers to know: Tuesday, May 15, 2018

Five things for pharma marketers to know: Tuesday, May 15, 2018

Feds join whistleblower case against Insys; Kleiner Perkins Caufield partner Seidenberg departs; Lilly strikes second acquisition deal in a week.

17 days that rocked WPP

17 days that rocked WPP

To say that Sir Martin Sorrell's rapid departure from WPP was a seismic event is an understatement. So just what happened in the days leading up to the fall of its CEO?

5 takeaways from Trump's drug pricing speech

5 takeaways from Trump's drug pricing speech

Pharma stocks were up after the President went easy on drugmakers.

Five things for pharma marketers to know: Monday, May 14, 2018

Five things for pharma marketers to know: Monday, May 14, 2018

Beam Therapeutics raises $87 million in Series A funding; Trump drug-pricing plan largely spares big pharma; Novartis regrets Cohen consulting pact.